227 related articles for article (PubMed ID: 30790642)
21. Wnt lipidation: Roles in trafficking, modulation, and function.
Hosseini V; Dani C; Geranmayeh MH; Mohammadzadeh F; Nazari Soltan Ahmad S; Darabi M
J Cell Physiol; 2019 Jun; 234(6):8040-8054. PubMed ID: 30341908
[TBL] [Abstract][Full Text] [Related]
22. Diverse chemical scaffolds support direct inhibition of the membrane-bound O-acyltransferase porcupine.
Dodge ME; Moon J; Tuladhar R; Lu J; Jacob LS; Zhang LS; Shi H; Wang X; Moro E; Mongera A; Argenton F; Karner CM; Carroll TJ; Chen C; Amatruda JF; Lum L
J Biol Chem; 2012 Jun; 287(27):23246-54. PubMed ID: 22593577
[TBL] [Abstract][Full Text] [Related]
23. Inhibition of PORCN Blocks Wnt Signaling to Attenuate Progression of Oral Carcinogenesis.
Peña-Oyarzún D; Flores T; Torres VA; Quest AFG; Lobos-González L; Kretschmar C; Contreras P; Maturana-Ramírez A; Criollo A; Reyes M
Clin Cancer Res; 2024 Jan; 30(1):209-223. PubMed ID: 37812478
[TBL] [Abstract][Full Text] [Related]
24. Fatty acylation of Wnt proteins.
Nile AH; Hannoush RN
Nat Chem Biol; 2016 Feb; 12(2):60-9. PubMed ID: 26784846
[TBL] [Abstract][Full Text] [Related]
25. Single-cell imaging of Wnt palmitoylation by the acyltransferase porcupine.
Gao X; Hannoush RN
Nat Chem Biol; 2014 Jan; 10(1):61-8. PubMed ID: 24292069
[TBL] [Abstract][Full Text] [Related]
26. Precise regulation of porcupine activity is required for physiological Wnt signaling.
Proffitt KD; Virshup DM
J Biol Chem; 2012 Oct; 287(41):34167-78. PubMed ID: 22888000
[TBL] [Abstract][Full Text] [Related]
27. Determination of the membrane topology of PORCN, an O-acyl transferase that modifies Wnt signalling proteins.
Galli LM; Anderson MO; Gabriel Fraley J; Sanchez L; Bueno R; Hernandez DN; Maddox EU; Lingappa VR; Burrus LW
Open Biol; 2021 Jun; 11(6):200400. PubMed ID: 34186010
[TBL] [Abstract][Full Text] [Related]
28. Stearoyl CoA desaturase is required to produce active, lipid-modified Wnt proteins.
Rios-Esteves J; Resh MD
Cell Rep; 2013 Sep; 4(6):1072-81. PubMed ID: 24055053
[TBL] [Abstract][Full Text] [Related]
29. Pharmacological inhibition of the Wnt acyltransferase PORCN prevents growth of WNT-driven mammary cancer.
Proffitt KD; Madan B; Ke Z; Pendharkar V; Ding L; Lee MA; Hannoush RN; Virshup DM
Cancer Res; 2013 Jan; 73(2):502-7. PubMed ID: 23188502
[TBL] [Abstract][Full Text] [Related]
30. Divergent effects of Porcupine and Wntless on WNT1 trafficking, secretion, and signaling.
Galli LM; Zebarjadi N; Li L; Lingappa VR; Burrus LW
Exp Cell Res; 2016 Sep; 347(1):171-183. PubMed ID: 27492485
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of CBP/β-catenin and porcupine attenuates Wnt signaling and induces apoptosis in head and neck carcinoma cells.
Kleszcz R; Szymańska A; Krajka-Kuźniak V; Baer-Dubowska W; Paluszczak J
Cell Oncol (Dordr); 2019 Aug; 42(4):505-520. PubMed ID: 31089983
[TBL] [Abstract][Full Text] [Related]
32. Suppression of Wnt/β-Catenin Signaling Is Associated with Downregulation of Wnt1, PORCN, and Rspo2 in Alzheimer's Disease.
Macyczko JR; Wang N; Zhao J; Ren Y; Lu W; Ikezu TC; Zhao N; Liu CC; Bu G; Li Y
Mol Neurobiol; 2023 Jan; 60(1):26-35. PubMed ID: 36215026
[TBL] [Abstract][Full Text] [Related]
33. Deletion of mouse Porcn blocks Wnt ligand secretion and reveals an ectodermal etiology of human focal dermal hypoplasia/Goltz syndrome.
Barrott JJ; Cash GM; Smith AP; Barrow JR; Murtaugh LC
Proc Natl Acad Sci U S A; 2011 Aug; 108(31):12752-7. PubMed ID: 21768372
[TBL] [Abstract][Full Text] [Related]
34. Multiple requirements of the focal dermal hypoplasia gene porcupine during ocular morphogenesis.
Bankhead EJ; Colasanto MP; Dyorich KM; Jamrich M; Murtaugh LC; Fuhrmann S
Am J Pathol; 2015 Jan; 185(1):197-213. PubMed ID: 25451153
[TBL] [Abstract][Full Text] [Related]
35. Wnts are dispensable for differentiation and self-renewal of adult murine hematopoietic stem cells.
Kabiri Z; Numata A; Kawasaki A; Edison ; Tenen DG; Virshup DM
Blood; 2015 Aug; 126(9):1086-94. PubMed ID: 26089398
[TBL] [Abstract][Full Text] [Related]
36. Porcupine Inhibition Disrupts Mitochondrial Function and Homeostasis in WNT Ligand-Addicted Pancreatic Cancer.
Aguilera KY; Le T; Riahi R; Lay AR; Hinz S; Saadat EA; Vashisht AA; Wohlschlegel J; Donahue TR; Radu CG; Dawson DW
Mol Cancer Ther; 2022 Jun; 21(6):936-947. PubMed ID: 35313331
[TBL] [Abstract][Full Text] [Related]
37. Targeting ligand-dependent wnt pathway dysregulation in gastrointestinal cancers through porcupine inhibition.
Flanagan DJ; Woodcock SA; Phillips C; Eagle C; Sansom OJ
Pharmacol Ther; 2022 Oct; 238():108179. PubMed ID: 35358569
[TBL] [Abstract][Full Text] [Related]
38. Identification of the WNT1 residues required for palmitoylation by Porcupine.
Miranda M; Galli LM; Enriquez M; Szabo LA; Gao X; Hannoush RN; Burrus LW
FEBS Lett; 2014 Dec; 588(24):4815-24. PubMed ID: 25451226
[TBL] [Abstract][Full Text] [Related]
39. Selective Irreversible Inhibitors of the Wnt-Deacylating Enzyme NOTUM Developed by Activity-Based Protein Profiling.
Suciu RM; Cognetta AB; Potter ZE; Cravatt BF
ACS Med Chem Lett; 2018 Jun; 9(6):563-568. PubMed ID: 29937983
[TBL] [Abstract][Full Text] [Related]
40. NOTUM is a potential pharmacodynamic biomarker of Wnt pathway inhibition.
Madan B; Ke Z; Lei ZD; Oliver FA; Oshima M; Lee MA; Rozen S; Virshup DM
Oncotarget; 2016 Mar; 7(11):12386-92. PubMed ID: 26848981
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
